Commentary
Commentary Whether one attends a scientific meeting devoted to high-energy extremity trauma, the diabetic foot, or musculoskeletal oncology, somewhere near the conclusion of the meeting will be either a presentation or a panel discussion directed toward the issue of limb salvage versus amputation. The participants will present their approach to this difficult clinical challenge, supported by little objective clinical data1.

Several attempts have been made to develop severity-of-injury scoring systems to guide trauma surgeons regarding whether they should direct their efforts toward meaningful limb salvage as opposed to performing primary limb amputation. To date, these efforts have not been able to provide a scoring system that avoids the subjective biases that impact our objective decision-making skills2.

The National Institutes of Health sponsored the Lower Extremity Assessment Project (LEAP) in order to provide surgeons with objective data on outcome expectations associated with mutilating limb injuries in civilian practice3. In this eight-clinical-center fourteen-million-dollar observational investigation, validated outcomes tools were used to follow the progress of 569 patients with high-energy lower-extremity injuries. Several subsequent publications from this ongoing observational database have addressed important clinical questions that previously had been treated on the basis of expert opinion or small non-case-controlled retrospective case series.

“The Military Extremity Trauma Amputation/Limb Salvage (METALS) Study. Outcomes of Amputation Versus Limb Salvage Following Major Lower-Extremity Trauma” by Doukas and co-authors provides us with very disturbing objective outcome information that may translate well to civilian practice. The design of this investigation was carefully crafted on the basis of the benchmark established by the LEAP investigation. It is clear from this carefully crafted database that clinical outcomes following high-energy trauma may impart more of a negative impact on health-related quality of life than we previously thought. The valuable link between this investigation and the LEAP study is the continuity provided by Ellen J. MacKenzie, PhD, who was intimately involved with the design of both investigations.